388 filings
Page 2 of 20
8-K
23dumh4l7 yhj
31 Oct 23
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
5:18pm
8-K
pp3ol7wrtskm8 ghh
27 Oct 23
Other Events
5:12pm
8-K
s2210n99
25 Oct 23
Alkermes plc Reports Third Quarter 2023 Financial Results
7:06am
8-K
q1wfk
23 Oct 23
Alkermes Presents First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress
8:27am
8-K
kfjmk9h eqlkgot7pk
30 Aug 23
Alkermes Announces Settlement With Teva Related to VIVITROL® Patent Litigation
7:14am
S-8
2jgo 4l2w
26 Jul 23
Registration of securities for employees
4:37pm
8-K
2ycs jvxrkv134t9ot
26 Jul 23
Alkermes plc Reports Second Quarter 2023 Financial Results
7:06am
8-K
sn92x a6oo2i6zuriw
6 Jul 23
Departure of Directors or Certain Officers
8:05am
8-K
p9537dvb
5 Jul 23
Entry into a Material Definitive Agreement
5:00pm
DFAN14A
ihnwpf1jcw2v
28 Jun 23
Additional proxy materials by non-management
5:04pm
DFAN14A
xxgf4rcp7 g2
28 Jun 23
Additional proxy materials by non-management
4:30pm
DEFA14A
6vu4g 9dgpef9st9skbj
26 Jun 23
Additional proxy soliciting materials
5:15pm
DFAN14A
06mgjjpkops udpkka
26 Jun 23
Additional proxy materials by non-management
5:00pm
DEFA14A
bjrji
26 Jun 23
Additional proxy soliciting materials
4:45pm
DEFA14A
jnslrtzmy3t ukc
26 Jun 23
Additional proxy soliciting materials
7:05am
DFAN14A
bediju2y1w8xpv
22 Jun 23
Additional proxy materials by non-management
4:33pm
DEFA14A
pv5n7lsbn5c
21 Jun 23
Additional proxy soliciting materials
4:22pm
DEFA14A
9j9lgg9h bgbx21
21 Jun 23
Additional proxy soliciting materials
9:30am